Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Canada Considers Performance-Based Outcome Reimbursement Deals For Oncology Drugs

Executive Summary

Manufacturers selling oncology drugs in Canada could soon face group price negotiations and performance-based reimbursement agreements as authorities in the country plan to improve access to oncology drugs.

Advertisement

Related Content

Multi-Company Product Listing Agreements On The Rise In Canada

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel